Annual Working Capital
$296.89 M
-$145.03 M-32.82%
December 31, 2023
Summary
- As of February 7, 2025, NAMS annual working capital is $296.89 million, with the most recent change of -$145.03 million (-32.82%) on December 31, 2023.
- During the last 3 years, NAMS annual working capital has risen by +$301.31 million (+6825.73%).
- NAMS annual working capital is now -32.82% below its all-time high of $441.92 million, reached on December 31, 2022.
Performance
NAMS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$396.62 M
-$3.43 M-0.86%
September 30, 2024
Summary
- As of February 7, 2025, NAMS quarterly working capital is $396.62 million, with the most recent change of -$3.43 million (-0.86%) on September 30, 2024.
- NAMS quarterly working capital is now -10.25% below its all-time high of $441.92 million, reached on December 31, 2022.
Performance
NAMS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NAMS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.8% | - |
| 3 y3 years | +6825.7% | -10.3% |
| 5 y5 years | +6825.7% | -10.3% |
NAMS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.8% | +435.2% | -10.3% | +615.0% |
| 5 y | 5-year | -32.8% | +6825.7% | -10.3% | +615.0% |
| alltime | all time | -32.8% | +6825.7% | -10.3% | +615.0% |
NewAmsterdam Pharma Company NV Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $396.62 M(-0.9%) |
| Jun 2024 | - | $400.05 M(-6.6%) |
| Mar 2024 | - | $428.10 M(+44.2%) |
| Dec 2023 | $296.89 M | $296.89 M(-22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $381.37 M(-13.7%) |
| Dec 2022 | $441.92 M(+696.7%) | $441.92 M(+121.4%) |
| Jun 2022 | - | $199.57 M(+259.8%) |
| Dec 2021 | $55.47 M(-1356.6%) | $55.47 M |
| Dec 2020 | -$4.41 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual working capital?
- What is the all time high annual working capital for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual working capital year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly working capital?
- What is the all time high quarterly working capital for NewAmsterdam Pharma Company NV?
What is NewAmsterdam Pharma Company NV annual working capital?
The current annual working capital of NAMS is $296.89 M
What is the all time high annual working capital for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual working capital is $441.92 M
What is NewAmsterdam Pharma Company NV annual working capital year-on-year change?
Over the past year, NAMS annual working capital has changed by -$145.03 M (-32.82%)
What is NewAmsterdam Pharma Company NV quarterly working capital?
The current quarterly working capital of NAMS is $396.62 M
What is the all time high quarterly working capital for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly working capital is $441.92 M